TissueGnostics joins the global fight against infectious diseases with our Global Alliance Against Pandemic Virus Threats Campaign!
TissueGnostics is a solution provider for Precision Medicine and provides fully integrated cutting-edge tissue cytometers including a multitude of configurations from multispectral & high-throughput scanning to contextual tissue cytometry. The goal of TissueGnostics is to bring the same type of phenotypical analysis of single cells from Flow Cytometry into tissue context. For more infomation about TissueGnostics and Precision Medicine, please follow the link to the dossier "FIGHT CANCER! The age of precision medicine has dawned".
TissueGnostics has been founded in 2003 and is now a globally active Austrian company with subsidiaries in the EU, the USA and China and customers on all continents.
The 7th generation of TissueGnostics’ analysis suite StrataQuest comes with many new and exciting features. Two of them we want to highlight are our AI solutions: the machine learning-based classifier for a quick and precise detection of morphological entities in tissue, and the novel Deep Neural Network (DNN) for more accurate nuclei detection in difficult conditions.
The DNN is a particularly useful and simple solution for nuclear segmentation in tissues with extremely high cellular density, weak signal intensity, or high variation in nuclei size and texture.
If you are interested in learning more about the new deep learning-based nuclei segmentation or the classifiers, please follow the link.